| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | ANIP Ani Pharmaceuticals Inc | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $67.69 | $16,922.50 | -0.4% | -11.4% | -7.9% | |
| May 13, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Conway Vikki L | See "remarks" | Sell | 15,219 | $16.74 | $254,807.15 | -100% | +1.2% | +3.6% | |
| May 13, 2024 | BCRX Biocryst Pharmaceuticals Inc | Gayer Charles K | Chief Commercial Officer | Buy | 30,000 | $5.47 | $164,100.00 | +10.8% | +37.3% | +78.7% | |
| May 13, 2024 | AKBA Akebia Therapeutics, Inc. | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 34,840 | $1.26 | $43,898.40 | -4.9% | -4.7% | +92.2% | |
| May 13, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $265.49 | $1,911,532.11 | -46.8% | +26.3% | +16.5% | |
| May 10, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 10,500 | $0.10 | $1,050.00 | +1.4% | - | - | |
| May 10, 2024 | EOLS Evolus, Inc. | Beaver Sandra67 | Chief Financial Officer | Sell | 2,423 | $12.72 | $30,814.26 | -1.6% | +2.2% | -23.1% | |
| May 10, 2024 | EOLS Evolus, Inc. | Moatazedi David68 | See Remarks | Sell | 16,051 | $12.72 | $204,126.99 | -2.3% | +2.2% | -23.1% | |
| May 10, 2024 | EOLS Evolus, Inc. | Avelar Rui67 | See Remarks | Sell | 3,441 | $12.72 | $43,760.57 | -0.9% | +2.2% | -23.1% | |
| May 9, 2024 | HIMS Hims & Hers Health, Inc. | Carroll Patrick Harrison52 | Chief Medical Officer | Sell | 10,000 | $13.00 | $130,000.00 | -5.4% | +24.1% | +302.2% | |
| May 9, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $263.67 | $1,898,392.88 | -31.5% | +21.1% | +13.3% | |
| May 7, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 3,000 | $0.11 | $330.00 | +0.1% | - | - | |
| May 7, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 3,600 | $263.82 | $949,737.25 | -32.1% | +22.3% | +15.3% | |
| May 6, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 20,000 | $0.10 | $1,900.00 | - | - | - | |
| May 6, 2024 | NBIX Neurocrine Biosciences Inc | Delaet Ingrid67 | Chief Regulatory Officer | Sell | 273 | $140.55 | $38,370.15 | -3.5% | +4.2% | -16.1% | |
| May 6, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $259.89 | $1,871,233.28 | -25.8% | +25.0% | +13.2% | |
| May 3, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 100,000 | $0.10 | $10,350.00 | - | - | - | |
| May 3, 2024 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 2,240 | $259.91 | $582,195.04 | -34.9% | +24.9% | +12.3% | |
| May 3, 2024 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 10,000 | $258.56 | $2,585,601.35 | -15.7% | +24.9% | +12.3% | |
| May 3, 2024 | UTHR United Therapeutics Corp | Sullivan Louis W62 | Director | Sell | 5,160 | $258.39 | $1,333,284.68 | -15.1% | +24.9% | +12.3% | |
| May 3, 2024 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 35,250 | $12.11 | $426,871.38 | -0.8% | +64.4% | +262.5% | |
| May 2, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 709,841 | $0.10 | $68,759.01 | +0.1% | - | - | |
| May 2, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $254.15 | $1,829,903.18 | -16.3% | +21.4% | +14.1% | |
| May 1, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $41.67 | $20,836.95 | -0.6% | +3.4% | -43.3% | |
| May 1, 2024 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 333,332 | $12.60 | $4,200,307.11 | -19.2% | +69.5% | +189.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.